A New Era for Treatment of Advanced Head and Neck Cancers

EP. 1: Underlying Biology of HPV-Positive and -Negative HNSCC

November 7th 2016

EP. 2: Prognostic Factors for HNSCC

November 7th 2016

EP. 3: HPV Testing in HNSCC

November 7th 2016

EP. 4: Factors Influencing Treatment Decisions for HNSCC

November 7th 2016

EP. 5: Locoregionally Advanced HNSCC

November 7th 2016

EP. 6: Goals of Therapy for HNSCC

November 7th 2016

EP. 7: Long-Term Toxicity in HNSCC

November 7th 2016

EP. 8: Surgery and Radiotherapy for HNSCC

November 7th 2016

EP. 9: Appropriate Use of Chemotherapy in HNSCC

November 7th 2016

EP. 10: Debates Surrounding Induction Chemotherapy in HNSCC

November 7th 2016

EP. 11: Unmet Needs in Recurrent HNSCC

November 7th 2016

EP. 12: Enter PD-1 Inhibitors; A New Paradigm for HNSCC

November 7th 2016

EP. 13: Pembrolizumab and Nivolumab in Recurrent HNSCC

November 7th 2016

EP. 14: Patient Selection for Pembrolizumab in HNSCC

November 7th 2016

EP. 15: Emerging Concepts for Immunotherapy in HNSCC

November 7th 2016

EP. 16: Immune-Based Approaches in the Curative Setting of HNSCC

November 7th 2016